J7614 – Levalbuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 0.5 mg

Long description

Levalbuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 0.5 mg

Short description

Levalbuterol non-comp unit

Pricing indicator

00 Not separately priced by Part B (bundled, not covered or Part A only)

Medicare coverage

D Special coverage instructions apply

BETOS category

D1G Drugs Administered through DME

Added

January 1, 2005

Last change

July 1, 2009 – No change

Nearby J codes

• J7606 – Formoterol fumarate, inhalation solution, fda approved final product, non-compounded, administered through dme, unit dose form, 20 micrograms
• J7607 – Levalbuterol, inhalation solution, compounded product, administered through dme, concentrated form, 0.5 mg
• J7608 – Acetylcysteine, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per gram
• J7609 – Albuterol, inhalation solution, compounded product, administered through dme, unit dose, 1 mg
• J7610 – Albuterol, inhalation solution, compounded product, administered through dme, concentrated form, 1 mg
• J7611 – Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg
• J7612 – Levalbuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 0.5 mg
• J7613 – Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg
• J7615 – Levalbuterol, inhalation solution, compounded product, administered through dme, unit dose, 0.5 mg
• J7620 – Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme
• J7622 – Beclomethasone, inhalation solution, compounded product, administered through dme, unit dose form, per milligram
• J7624 – Betamethasone, inhalation solution, compounded product, administered through dme, unit dose form, per milligram
• J7626 – Budesonide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, up to 0.5 mg
• J7627 – Budesonide, inhalation solution, compounded product, administered through dme, unit dose form, up to 0.5 mg
• J7628 – Bitolterol mesylate, inhalation solution, compounded product, administered through dme, concentrated form, per milligram
• J7629 – Bitolterol mesylate, inhalation solution, compounded product, administered through dme, unit dose form, per milligram